Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

EC145 (Ovarian Cancer) ' Analysis and Forecasts to 2020

176 views

Published on

EC145 (Ovarian Cancer) ' Analysis and Forecasts to 2020SummaryGlobalData's pharmaceuticals report, 'EC145 (Ovarian Cancer) - Analysis and Forecasts to 2020' provides EC145 sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2016-2020). The report also includes information on Ovarian Cancer market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.Scope- Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)- Analysis and review of EC145 including sales data - Qualitative and quantitative assessment of market space- Analysis of the trends, drivers and restraints shaping and defining the markets- In-depth analysis of EC145 including efficacy, safety, pricing, competition and other details which influence its sales potential- Detailed sales forecast for 2016-2020 for EC145 in the seven major marketsReasons to buy- Understand and capitalize by identifying products that are most likely to ensure a robust return- Stay ahead of competition by understanding the changing competitive landscape- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential- Make more informed business decisions from insightful and in-depth analysis of the drug's performance - Examine the historical sales performance of a drug in seven major markets- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

  • Be the first to comment

  • Be the first to like this

EC145 (Ovarian Cancer) ' Analysis and Forecasts to 2020

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!EC145 (Ovarian Cancer) Analysis and Forecasts to 2020Published on October 2011 Report SummaryEC145 (Ovarian Cancer) Analysis and Forecasts to 2020SummaryGlobalDatas pharmaceuticals report, EC145 (Ovarian Cancer) - Analysis and Forecasts to 2020 provides EC145 sales estimates forUS, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitivelandscape, and analysis of sales performance during the forecast period (2016-2020). The report also includes information onOvarian Cancer market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary andsecondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both fromcompany and industry-specific third party sources, put together with in-house analysis, by GlobalDatas team of industry experts.Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.Scope- Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)- Analysis and review of EC145 including sales data- Qualitative and quantitative assessment of market space- Analysis of the trends, drivers and restraints shaping and defining the markets- In-depth analysis of EC145 including efficacy, safety, pricing, competition and other details which influence its sales potential- Detailed sales forecast for 2016-2020 for EC145 in the seven major marketsReasons to buy- Understand and capitalize by identifying products that are most likely to ensure a robust return- Stay ahead of competition by understanding the changing competitive landscape- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential- Make more informed business decisions from insightful and in-depth analysis of the drugs performance- Examine the historical sales performance of a drug in seven major markets- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets Table of Content1 Table of Contents 21.1 List of Tables 31.2 List of Figures 32 Introduction 42.1 Ovarian Cancer 4EC145 (Ovarian Cancer) Analysis and Forecasts to 2020 (From Slideshare) Page 1/5
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!2.2 Ovarian Cancer Market 42.3 Epidemiology 42.4 Etiology 62.4.1 Age 62.4.2 Inherited Gene Mutations 62.4.3 A Previous Cancer Diagnosis 62.4.4 Early Menstruation or Late menopause 72.4.5 Family History of Ovarian Cancer 72.5 GlobalData Market Forecasts Report Guidance 83 Ovarian Cancer: Market Characterization 93.1 Ovarian Cancer Market 93.2 Ovarian Cancer Market Forecasts and CAGR 93.3 Drivers for Ovarian Cancer Market 103.3.1 High Incidence 103.3.2 High Mortality Rate 113.3.3 Increased Use of Chemotherapy in Ovarian Cancer 123.3.4 Emergence of Targeted Drugs 123.3.5 Recurrence of Tumor 123.3.6 Low Initial Diagnosis Rate 124 Tumor-Node-Metastases (TNM) Classification of Ovarian Cancer 135 EC145 165.1 Introduction 165.2 Mechanism of Action 165.3 Clinical Studies 165.3.1 Phase III Study 165.3.2 Phase II Study 165.4 Approval Status of EC145 165.5 Factors Affecting Sales 175.5.1 Mechanism of Action 175.5.2 Efficacy and Safety Profile of EC145 175.5.3 Absence of Competition in the Third Line Treatment 175.6 Drug Evaluation 175.6.1 Drug Risk Benefit Score 175.6.2 Intensity of Competition 185.7 Sales Forecasts 185.7.1 Target Patient Pool of EC145 185.7.2 Dosing 195.7.3 Market Penetration 195.7.4 Annual Cost of Therapy 195.7.5 Sales Projections of EC145 206 Ovarian Cancer Market: Appendix 276.1 Market Definitions 276.2 List of Abbreviations 276.3 Research Methodology 276.3.1 Coverage 276.3.2 Secondary Research 286.3.3 Forecasting 286.3.4 Number of Patients Approved to take the Drug 28EC145 (Ovarian Cancer) Analysis and Forecasts to 2020 (From Slideshare) Page 2/5
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!6.3.5 Net Penetration of Drug 296.3.6 Net Annual Dosing 306.3.7 Annual Cost of Therapy 306.3.8 Primary Research 306.3.9 Expert Panels 306.4 Contact Us 306.5 Disclaimer 306.6 Sources 311.1 List of TablesTable 1: Ovarian Cancer, Incidences and Mortality, 20082030 6Table 2: Ovarian Cancer, Global, Market Size Forecasts ($m), 20092020 9Table 3: Detailed TNM Classification 14Table 4: Drug Risk Benefit Score of EC145 17Table 5: Estimated Annual Cost of Therapy of EC145, 2016 19Table 6: EC145, Ovarian Cancer, Global, Sales Forecasts ($m), 20162020 20Table 7: EC145, Ovarian Cancer, The US, Sales Forecasts ($m), 20162020 21Table 8: EC145, Ovarian Cancer, France, Sales Forecasts ($m), 20162020 22Table 9: EC145, Ovarian Cancer, Germany, Sales Forecasts ($m), 20162020 23Table 10: EC145, Ovarian Cancer, Italy, Sales Forecasts ($m), 20162020 24Table 11: EC145, Ovarian Cancer, Spain, Sales Forecasts ($m), 20162020 251.2 List of FiguresFigure 1: Distribution by Incidence and Mortality, Most Frequently Diagnosed Cancers, Worldwide, 2010 5Figure 2: Ovarian Cancer, Global, Market Size Forecasts ($m), 20092020 9Figure 3: Ovarian Cancer, Worldwide, Incidence (in million), 2008-2030 10Figure 4: Oncology, Worldwide, Incidence (in million), 2008-2030 11Figure 5: Ovarian Cancer, Worldwide, Mortality (in million), 2008-2030 11Figure 6: Broad Classification of Ovarian Cancer 13Figure 7: Classification of Ovarian Cancer 15Figure 8: Drug Model Diagram of EC145 18Figure 9: EC145, Ovarian Cancer, Global, Sales Forecasts ($m), 20162020 20Figure 10: EC145, Ovarian Cancer, The US, Sales Forecasts ($m), 20162020 21Figure 11: EC145, Ovarian Cancer, France, Sales Forecasts ($m), 20162020 22Figure 12: EC145, Ovarian Cancer, Germany, Sales Forecasts ($m), 20162020 23Figure 13: EC145, Ovarian Cancer, Italy, Sales Forecasts ($m), 20162020 24Figure 14: EC145, Ovarian Cancer, Spain, Sales Forecasts ($m), 20162020 25Figure 15: EC145, Ovarian Cancer, Global, Sales Distribution (%), 2020 26Figure 16: Drug Model Diagram 29Figure 17: Patients Approved for the Drug 29EC145 (Ovarian Cancer) Analysis and Forecasts to 2020 (From Slideshare) Page 3/5
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. EC145 (Ovarian Cancer) Analysis and Forecasts to 2020 Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 000.00 Quantity: _____ Site License--USD 4 000.00 Quantity: _____ Corporate License--USD 6 000.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________EC145 (Ovarian Cancer) Analysis and Forecasts to 2020 (From Slideshare) Page 4/5
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93EC145 (Ovarian Cancer) Analysis and Forecasts to 2020 (From Slideshare) Page 5/5

×